Sofosbuvir/daclatasvir combination could be produced for $200 per hepatitis C cure
France approves PrEP
Almost half of US Medicaid recipients denied funding for hepatitis C treatment, 4-state study shows
How do we treat the world? Experts discuss moving to universal HIV treatment
Retreat of international donors and neglect of national governments threatens harm reduction services